FDA grants quick review for 3 psychedelic drug trials

The Food and Drug Administration granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. NBC News' Erika Edwards reports on the specific drugs under review and how the FDA determines whether they are safe and effective.
Source
NBC News
Opens original article in a new tab



